Singapore Drug R&D Consortium Draws GSK, Pfizer, Siemens As Members
This article was originally published in PharmAsia News
Executive Summary
Singapore's Agency for Science, Technology and Research has formed a consortium with multinational giants GlaxoSmithKline, Pfizer and Siemens to move drugs from trials to markets in a more efficient fashion.